A photo of Tracy Glauser.

Associate Director, Cincinnati Children's Research Foundation

Director, Comprehensive Epilepsy Center

Co-Director, Genetic Pharmacology Service

Professor, UC Department of Pediatrics



Board Certified

Best Doctors logo

My Biography & Research


Tracy A. Glauser, MD, is director of the Comprehensive Epilepsy Center and co-director of the Genetic Pharmacology Service at Cincinnati Children’s Hospital Medical Center and professor of pediatrics in the University of Cincinnati College of Medicine. Dr. Glauser received his medical degree, cum laude, from Jefferson Medical College in Philadelphia, PA. He completed his residency in pediatrics at the John Hopkins Hospital in Baltimore, MD, and fellowship in child neurology at The Children’s Hospital of Philadelphia, University of Pennsylvania in Philadelphia, PA. Dr. Glauser completed a National Institute of Neurological Disorders and Stroke research fellowship in pediatric neurology and was a fellow in epilepsy and electroencephalography at St. Louis Children’s Hospital, Washington University School of Medicine in St. Louis, Missouri.

Dr. Glauser has authored and co-authored more than 130 articles and book chapters, been involved with the development of six evidence-based guidelines about epilepsy therapy and given over 150 invited lectures throughout the world. He has been the principal investigator on multiple NIH grants. Currently, Dr. Glauser directs the NIH funded Childhood Absence Epilepsy clinical trial involving 32 pediatric centers around the United States. Dr. Glauser’s fields of expertise are pediatric neurology, pediatric epilepsy, clinical pharmacology and pharmacogenetics.

Clinical Interests

Epilepsy; pharmacogenetics; clinical pharmacology

Research Interests

Clinical pharmacology; pharmacogenetics; antiepileptic clinical trials 

Academic Affiliation

Professor, UC Department of Pediatrics


Neurology, Epilepsy, Genetic Pharmacology, Neurology, Clinical Pharmacology

Science Blog

GRIN Network Shows Early Success in Big-Data Sharing

Big Data and Analytics

GRIN Network Shows Early Success in Big-Data Sharing

Tracy A. Glauser, MD9/5/2019

Reimagining How We Think About Our Brains

Mind Brain Behavior

Reimagining How We Think About Our Brains

Lori J. Stark, PhD, ABPP, Tracy A. Glauser, MD7/3/2019

My Education

MD: Jefferson Medical College, Philadelphia, PA, 1985.

Residency: Johns Hopkins Hospital, Baltimore, MD.

Fellowship: St. Louis Children's Hospital, St. Louis, MO.

Certification: Pediatrics, 1990; Neurology (with special competence in child neurology), 1991.

My Publications

Selected Publication

The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. Mandl, KD; Glauser, T; Krantz, ID; Avillach, P; Bartels, A; Beggs, AH; Biswas, S; Bourgeois, FT; Corsmo, J; Dauber, A; et al. Genetics in Medicine. 2020; 22:371-380.

Development of information sharing in language neocortex in childhood-onset drug-resistant epilepsy. Arya, R; Ervin, B; Wilson, JA; Byars, AW; Rozhkov, L; Buroker, J; Horn, PS; Scholle, C; Fujiwara, H; Greiner, HM; et al. Epilepsia. 2019; 60:393-405.

Pretreatment behavior and subsequent medication effects in childhood absence epilepsy. Shinnar, RC; Shinnar, S; Cnaan, A; Clark, P; Dlugos, D; Hirtz, DG; Hu, F; Liu, C; Masur, D; Weiss, EF; et al. Neurology. 2017; 89:1698-1706.

Pretreatment seizure semiology in childhood absence epilepsy. Kessler, SK; Shinnar, S; Cnaan, A; Dlugos, D; Conry, J; Hirtz, DG; Hu, F; Liu, C; Mizrahi, EM; Moshe, SL; et al. Neurology. 2017; 89:673-679.

Pharmacogenetics of Antiepileptic Drug Efficacy in Childhood Absence Epilepsy. Glauser, TA; Holland, K; O'Brien, VP; Keddache, M; Martin, LJ; Clark, PO; Cnaan, A; Dlugos, D; Hirtz, DG; Shinnar, S; et al. Annals of Neurology. 2017; 81:444-453.

Second monotherapy in childhood absence epilepsy. Cnaan, A; Shinnar, S; Arya, R; Adamson, PC; Clark, PO; Dlugos, D; Hirtz, DG; Masur, D; Glauser, TA; Study, CA E. Neurology. 2017; 88:182-190.

Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial. Shinnar, S; Cnaan, A; Hu, F; Clark, P; Dlugos, D; Hirtz, DG; Masur, D; Mizrahi, EM; Moshe, SL; Glauser, TA; et al. Neurology. 2015; 85:1108-1114.

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months. Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Adamson, PC; Study, CA E. Epilepsia. 2013; 54:141-155.

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy. Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Capparelli, EV; Adamson, PC; Study, CA E. The New England journal of medicine. 2010; 362:790-799.

Supporting Treatment Adherence Regimens in young children with epilepsy and their families: Trial design and baseline characteristics. Modi, AC; Glauser, TA; Guilfoyle, SM. Contemporary Clinical Trials. 2020; 90:105959-105959.